Reporting guidelines for population pharmacokinetic analyses.

about

Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation Commentary on the MID3 Good Practices Paper.

P2860

Q36734132-8880B17F-F30C-486F-9701-83C4E6F1560F Q38707591-83918378-2788-42FF-A8F6-AA5BAD257A5F

P2860

Reporting guidelines for population pharmacokinetic analyses.

Item

http://www.wikidata.org/entity/Q35607607

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Reporting guidelines for population pharmacokinetic analyses.

@ast

Reporting guidelines for population pharmacokinetic analyses.

@en

type

Item

label

Reporting guidelines for population pharmacokinetic analyses.

@ast

Reporting guidelines for population pharmacokinetic analyses.

@en

prefLabel

Reporting guidelines for population pharmacokinetic analyses.

@ast

Reporting guidelines for population pharmacokinetic analyses.

@en

P1476

Reporting guidelines for population pharmacokinetic analyses.

@en

P2093

Bela Patel

http://www.w3.org/2001/XMLSchema#string

Christoffer Wenzel Tornøe

http://www.w3.org/2001/XMLSchema#string

Helen Kastrissios

http://www.w3.org/2001/XMLSchema#string

Kevin Dykstra

http://www.w3.org/2001/XMLSchema#string

Nidal Al-Huniti

http://www.w3.org/2001/XMLSchema#string

Nitin Mehrotra

http://www.w3.org/2001/XMLSchema#string

Pravin Jadhav

http://www.w3.org/2001/XMLSchema#string

Wonkyung Byon

http://www.w3.org/2001/XMLSchema#string

Yaning Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Ways to fit a PK model with some data below the quantification limit.

A guide for reporting the results of population pharmacokinetic analyses: a Swedish perspective.

Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.

Guidelines for the quality control of population pharmacokinetic-pharmacodynamic analyses: an industry perspective.

Pharmacometrics as a discipline is entering the "industrialization" phase: standards, automation, knowledge sharing, and training are critical for future success.

Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance.

Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective.

P2888

s10928-015-9417-1

P304

301-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10928-015-9417-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275667708

http://www.w3.org/2001/XMLSchema#string

P698

25925797

http://www.w3.org/2001/XMLSchema#string

P932

4432104

http://www.w3.org/2001/XMLSchema#string

Reporting guidelines for population pharmacokinetic analyses.

about

P2860

P2860

Reporting guidelines for population pharmacokinetic analyses.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932